GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pfizer PFIZER.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

3,917.90

+1.61%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹25.20bn

FY2017FY2026

Net income

₹7.22bn

FY2017FY2026

Free cash flow

₹11.18bn

FY2017FY2026

Shareholders' equity

₹42.03bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹25.20bn₹22.81bn₹21.93bn₹24.25bn₹26.11bn₹22.40bn₹21.52bn₹20.82bn₹19.69bn₹19.66bn
Gross profit₹12.10bn₹14.66bn₹13.95bn₹15.47bn₹16.58bn₹14.38bn₹13.53bn₹13.28bn₹12.22bn₹11.61bn
Research and development—————————₹275.0m
Operating income₹8.46bn₹10.37bn₹9.61bn₹11.53bn₹11.80bn₹10.11bn₹9.00bn₹8.87bn₹8.01bn₹7.53bn
Net income₹7.22bn₹7.68bn₹5.51bn₹6.24bn₹6.13bn₹4.98bn₹5.09bn₹4.29bn₹3.60bn₹3.37bn
Diluted earnings per share157.90167.79120.51136.37133.89108.76111.3093.7778.7173.61

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹49.22bn₹49.11bn₹42.29bn₹40.01bn₹39.01bn₹32.66bn₹44.05bn₹39.40bn₹36.90bn₹32.71bn
Cash and short-term investments₹30.88bn₹28.01bn₹20.27bn₹18.40bn₹16.33bn₹10.98bn₹21.95bn₹19.14bn₹17.72bn₹15.23bn
Total liabilities₹7.19bn₹6.94bn₹6.33bn₹7.93bn₹10.36bn₹8.73bn₹10.10bn₹9.29bn₹10.07bn₹8.52bn
Debt₹702.3m₹1.08bn₹945.4m₹1.34bn₹1.67bn₹1.06bn₹1.28bn₹25.0m₹25.0m₹25.0m
Shareholders' equity₹42.03bn₹42.17bn₹35.96bn₹32.07bn₹28.64bn₹23.93bn₹33.95bn₹30.11bn₹26.83bn₹24.19bn
Shares outstanding46m46m46m46m46m46m46m46m46m46m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹11.44bn₹6.60bn₹2.57bn₹3.56bn₹6.67bn₹4.27bn₹3.23bn₹978.1m₹3.32bn₹3.29bn
Capital spending−₹252.3m−₹281.5m−₹189.3m−₹649.8m−₹153.1m−₹177.0m−₹168.9m−₹44.9m−₹1.03bn−₹252.9m
Free cash flow₹11.18bn₹6.32bn₹2.38bn₹2.91bn₹6.52bn₹4.10bn₹3.06bn₹933.2m₹2.29bn₹3.04bn
Dividends paid−₹7.52bn−₹1.60bn−₹1.83bn−₹2.97bn−₹1.60bn−₹15.19bn−₹1.03bn−₹910.5m−₹917.3m−₹686.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹6.53bn₹6.29bn₹6.45bn₹6.42bn₹6.03bn₹5.92bn₹5.38bn₹5.89bn
Gross profit₹4.13bn₹3.17bn₹3.06bn₹4.14bn₹3.92bn₹3.84bn₹3.41bn₹3.78bn
Operating income₹2.33bn₹2.21bn₹2.14bn₹2.16bn₹2.96bn₹2.44bn₹2.45bn₹2.77bn
Net income₹2.04bn₹2.00bn₹1.42bn₹1.89bn₹1.92bn₹3.31bn₹1.28bn₹1.58bn
Diluted earnings per share44.6943.6731.0041.3241.9172.3427.8934.61
Cash from operations———₹5.99bn—₹6.60bn—₹3.49bn
Capital spending———−₹103.0m—−₹281.0m—−₹90.0m
Free cash flow———₹5.89bn—₹6.32bn—₹3.40bn
Total assets—₹49.22bn—₹46.06bn—₹49.11bn—₹44.59bn
Cash and short-term investments₹30.88bn₹30.88bn₹27.04bn₹27.06bn₹27.83bn₹28.01bn₹22.81bn₹22.81bn
Debt—₹341.5m—₹898.3m—₹1.08bn—₹747.0m
Shareholders' equity₹42.03bn₹42.03bn₹38.48bn₹38.48bn₹42.17bn₹42.17bn₹37.51bn₹37.51bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1.3%2.4%2.3%
Operating income-9.8%-3.5%0.7%
Net income5.0%7.7%9.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin55.7%59.6%61.1%61.3%
Operating margin39.2%42.4%43.4%42.2%
Net margin31.0%28.3%26.5%23.4%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings24.429.643.731.333.146.545.942.034.025.9
Price to sales7.010.011.08.17.810.310.98.76.24.4

Dividends and splits

Per share, in the currency the company pays

Paid for 11 years. Last went ex-dividend on 17 Jul 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year75.00130.0035.005.0065.005.00330.0022.50
  • 2-for-1 split · 14 Jun 2000

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.